Background Lung cancer incidence and mortality continue to rise in China, highlighting the need for a deeper understanding of its epidemiology and optimal screening targets. Methods A total of 10,560 participants with 5–30 mm pulmonary nodules incidentally detected via low-dose computed tomography (LDCT)/CT were enrolled from 23 hospitals (October 2018–May 2021) and followed for 2–3 years for evaluation of circulating tumor DNA (ctDNA) biomarkers to distinguish malignant and benign nodules. Demographic, clinical, and imaging data were collected and analyzed. Lung cancer risk factors were assessed using stepwise single and multiple-factor binary logistic regression. This study reports only the baseline epidemiological characteristics of the population and the associated risk factors of lung cancer. Results A higher proportion of females (56.56%) were present across all age groups, with a median age of 53 years (45–62), younger than males (55 years [46–63], P < 0.001). While 97.1% of females and 37.8% of males were non-smokers, and 68.65% of participants had no occupational exposure, 71.10% had a history of second-hand smoke exposure. Most nodules were solitary (81.24%), sub-centimeter (78.22%), and non-solid (62.49%). Malignancy was identified in 17.33% of nodules, with 97.32% classified as early-stage lung adenocarcinoma (AJCC stage 0–I: 90.35%). The malignant rate increased with age and nodule size and was also associated with multiple nodules, ground-glass nodules (GGNs), upper lobe location, and female sex. Proportion of patients with malignant nodules was similar between non-high-risk (21.04%) and high-risk (17.92%) groups based on current Chinese screening guidelines, while proportions of benign nodules were notably high for solid nodules (37.21%) and small nodules (20.15%). Conclusion Our large-scale investigation provides updated data to guide future precise clinical management of pulmonary nodules, with a particular focus on younger females and reducing overtreatment.
目的:探讨超声引导下前锯肌平面(SP)阻滞对乳腺癌改良根治术患者血流动力学、血清疼痛介质、免疫功能的影响.方法:选择2020年9月-2022年5月期间我院收治的120例乳腺癌改良根治术患者,采用随机双盲对照原则将患者分为对照组和研究组,各为60例.对照组患者接受常规麻醉,研究组患者在常规麻醉基础上接受超声引导下SP阻滞.观察两组患者的镇静镇痛效果,对比两组患者疼痛介质、血流动力学及免疫功能的变化情况,记录两组围术期间不良反应发生情况.结果:研究组手术开始后10 min、术毕心率(HR)、平均动脉压(MAP)高于对照组(P<0.05).研究组术后24hCD8+低于对照组,CD3+、CD4+、CD4+/CD8+高于对照组(P<0.05).研究组术后24h神经肽Y(NPY)、前列腺素E2(PGE2)、P物质(SP)低于对照组(P<0.05).研究组术后24 h疼痛视觉模拟评分(VAS)评分低于对照组,Ramsay镇静评分高于对照组(P<0.05).两组不良反应发生率对比,无统计学差异(P>0.05).结论:超声引导下SP阻滞可加强乳腺癌改良根治术患者的镇静镇痛效果,维持血流动力学稳定,降低血清疼痛介质,减轻免疫抑制.
In December 2019, the COVID-19 pandemic quickly spread throughout China and beyond, posing enormous global challenges. With prompt, vigorous, and coordinated control measures, mainland China contained the spread of the epidemic within two months and halted the epidemic in three months. Aggressive containment strategy, hierarchical management, rational reallocation of resources, efficient contact tracing, and voluntary cooperation of Chinese citizens contributed to the rapid and efficient control of the epidemic, thus promoting the rapid recovery of the Chinese economy. This review summarizes China's prevention and control strategies and other public health measures, which may provide a reference for the epidemic control in other countries.
目的 探讨血清前白蛋白(PAB)动态变化对首次经内镜逆行性胰胆管造影(ERCP)胆道支架置入术治疗恶性梗阻性黄疸(MOJ)患者生存的预测价值.方法 回顾性分析首次经ERCP支架置入术解除梗阻的119例MOJ患者的临床资料.根据患者生存期是否大于1年分为生存组和死亡组,收集患者术前及术后7d的肝功能指标,计算出各指标动态变化率(术后7d/术前).利用受试者工作特征(ROC)曲线确定PAB动态变化率的最佳截断值,根据界值将患者分为高低2组,Kaplan-Meier法绘制2组患者的生存曲线,Cox比例风险模型分析影响患者长期生存预后的危险因素.结果 119例患者中1年生存率45.4%(54/119),病死率54.6%(65/119).生存组PAB动态变化率为1.1(0.9,1.4),死亡组为0.9(0.7,1.0),生存组高于死亡组(P<0.05);ROC分析提示PAB动态变化率预测死亡的ROC曲线下面积为0.799(95%CI:0.704~0.895),PAB动态变化率最佳截断值为1.008;生存分析显示低PAB动态变化率组的1年累积生存率低于高PAB动态变化率组(P<0.01).多因素Cox比例风险模型分析显示,PAB动态变化率较低是MOJ患者ERCP术后长期生存的独立危险因素.结论 PAB动态变化率可作为MOJ患者潜在的预后判断指标.
目的 观察一期实施孙氏手术和升主动脉—右侧锁骨下动脉血管转流术治疗急性Stanford A型主动脉夹层(TAAD)合并迷走右锁骨下动脉(ARSA)患者的效果.方法 急性TAAD合并ARSA患者5例,均行全主动脉弓置换+支架象鼻植入术(孙氏手术),ARSA近端结扎,升主动脉—右侧锁骨下动脉血管转流术,根部行无冠窦补片,"三明治"加固缝合.3例行主动脉瓣右无交界悬吊加固.结果 无手术死亡患者,手术时间(8.96±1.60)h,体外循环时间(258.26±36.56)min,主动脉阻断时间(156.36±26.33)min,双侧脑灌注时间(36.60±6.12)min.1例术前一侧下肢缺血的患者术后出现急性肾功能衰竭,给予床边血液滤过,出院时肾功能恢复正常.3例行主动脉瓣右无交界悬吊加固的患者,出院前复查心脏彩超示主动脉瓣无反流.结论 一期实施孙氏手术和升主动脉—右侧锁骨下动脉血管转流术治疗急性Stanford A型主动脉夹层合并ARSA的患者临床效果好.
目的 多数鼻咽癌患者伴有颈部淋巴结转移.文中观察鼻咽癌患者的临床特征,分析伴颈淋巴结转移者的诊治策略及其对预后的影响.方法 随访94例鼻咽癌患者,并按照是否行颈淋巴结活检及活检方式分为淋巴结穿刺活检组、切开活检组、原发灶活检组3组,分析各组患者的最终结局转归.结果 所有94例鼻咽癌患者总随访时间为16~144个月,中位随访时间为84个月.穿刺活检组、切开活检组、原发灶活检组的3年生存率分别为79.4%、72.4%、80.6%;5年生存率分别为70.6%、44.8%、67.7%;94例患者5年总生存率为59.6%.采用Kaplan-Meier法进行3组间的生存率分析,Log-rank检验显示差异有统计学意义(P<0.05).结论 颈部淋巴结穿刺活检对鼻咽癌患者的最终结局转归影响有限,但切开活检者预后相对较差.早发现、早治疗以及原发灶活检确诊是鼻咽癌诊治的重要策略.
72岁男性患者,因布鲁氏杆菌感染导致右侧髂总动脉假性动脉瘤形成,行手术治疗。手术采用人工血管原位重建术式,术中完整游离了动脉瘤,在扩大清创的基础上,切除主动脉瘤体,用人工血管重建近远端血运,恢复正常解剖关系,人工血管吻合口表面填塞缝固大网膜。术后根据培养结果规范应用抗生素,术后恢复良好,复查血管通畅。
目的 咽喉部肿瘤切除术后选择合适的修复方法是影响患者术后恢复的重要因素.文中旨在探讨胸骨舌骨肌组织瓣在保留喉功能的梨状窝内侧壁癌患者手术中的应用.方法 回顾性分析2014年12月到2021年1月东部战区总医院耳鼻咽喉头颈外科术中利用胸骨舌骨肌组织瓣进行喉功能重建的22例梨状窝内侧壁癌患者临床资料.术前先评估声门旁间隙的侵犯情况,6例(27.27%)声门旁间隙无明显受累者术中制作胸骨舌骨肌肌筋膜瓣,行梨状窝内侧壁切除+胸骨舌骨肌筋膜修补咽腔缺损;9(40.9%)例声门旁间隙部分受累者制作胸骨舌骨肌-舌骨组织瓣,术中行梨状窝内侧壁切除+患侧水平半喉切除+胸骨舌骨肌-舌骨组织瓣重建喉功能;7(31.81%)例声门旁间隙消失者术中制作胸骨舌骨肌-舌骨组织瓣并行患侧梨状窝内侧壁切除+患侧垂直半喉切除+胸骨舌骨肌-舌骨组织瓣喉功能重建.评估其临床治疗效果.结果 所有患者手术切口均I期愈合,无咽瘘及喉狭窄发生;术后恢复吞咽功能平均(16.0±4.5)d.术后6个月内顺利拔管21 (95.4%)例.1例患者发生吸入性肺炎经治疗后于12个月拔管,最终拔管率达到100%.结论 梨状窝内侧壁癌患者术前重点评估声门旁间隙侵犯程度,选择胸骨舌骨肌组织瓣进行喉功能重建,手术创伤小、恢复好,并发症少,值得临床推荐.
1 病例资料 患者男性,65岁.因"皮肤巩膜黄染、尿黄2天"于2020年4月14日入本院.患者入院前2天不明原因出现全身皮肤及巩膜黄染,小便呈浓茶样改变,伴头晕、乏力、口干、食欲减退.院外查血常规:红细胞2. 40 × 1012/L,血红蛋白浓度89 g/L,平均血红蛋含白含量37. 2 pg,平均红细胞体积111. 2 fl,红细胞比容26. 7%;尿常规:深黄色,隐血(+++),蛋白质(+++),胆红素(+),尿胆原(+);肝功能:总胆红素522. 4 μmol/L,直接胆红素63. 79 umol/L,间接胆红素458. 61 μmol/L;α-羟丁酸脱氢酶897 U/L,乳酸脱氢酶963 U/L;腹部彩超:肝胆胰脾肾未见明显异常.
目的 探讨金嗓散结胶囊联合雾化吸入治疗声带息肉的临床疗效.方法 选择2018年9月至2020年6月声带息肉患者78例,随机数字法分为试验组41例及对照组37例.对照组给予地塞米松磷酸钠等雾化吸入治疗,试验组给予金嗓散结胶囊联合雾化吸入治疗.治疗4周末,比较两组临床疗效、声带息肉组织炎性因子及相关生长因子表达.结果 试验组有效率92.68%高于对照组75.68%,差异有统计学意义(P>0.05).声带息肉组织白细胞介素-6(IL-6)、白细胞介素1β(IL-1β)、肿瘤坏死因子-α(TNF-α)、血管内皮生长因子、转化生长因子-β1及碱性成纤维生长因子表达均低于对照组,差异有统计学意义(P<0.05).结论 金嗓散结胶囊联合雾化吸入治疗有助于提高声带息肉患者临床疗效,可能与拮抗慢性炎症浸润、抑制相关生长因子表达等因素有关.
目的 探讨眶底及上颌窦前壁原始神经外胚层肿瘤/尤文氏肉瘤(ESFTs)这一罕见疾病的临床特点.方法 报道1例儿童ESFTs的临床特征、影像学表现、病理学特征,探讨其诊断、鉴别诊断、治疗及预后,并通过文献复习了解该病早期诊断要点.结果 该例患儿肿瘤病理上以小圆细胞为主要结构,细胞免疫组化为CD99的高表达.治疗方法 为手术切除加放化疗,患者术后随访21个月未出现肿瘤复发及远处转移征象.结论 头颈部肿瘤高度恶性肿瘤ESFTs影像学检查有一定的诊断意义,但是没有特异性,明确诊断主要依靠免疫组化检查.确诊后应尽可能早期手术,以免贻误治疗时机.预后较差,手术切除加放化疗能改善患者预后.
目的 研究耳鼻咽喉科门诊行舌下免疫治疗(SLIT)变应性鼻炎(AR)患者的脱落率、脱落特点及脱落原因.方法 通过电话随访2018年5-8月东部战区总医院耳鼻咽喉科门诊行SLIT的AR患者343例,男214例,女129例,年龄3~55岁.根据年龄分为5组:学龄前组(3~6岁),学龄组(7~12岁),青春期组(13~20岁),青年期组(21~40岁),中年期组(41~60岁).分析患者的脱落率.结果 ①343例患者具有完整随访资料的患者299例,其中男194例,女105例.学龄前组27例,学龄组91例,青春期组104例,青年期组66例,中年期组11例.年龄4~52岁;②随访的299例患者中,用药6个月后脱落率为51.17%;1年后脱落率为59.20%;2年后脱落率为74.25%.停药例数最多的月份位于用药的第3、4个月.男女之间的脱落率比较无差异.不同年龄组间的脱落率比较无差异;③7例患者因不良反应停止用药,占脱落患者3.15%;④排名前四的脱落原因依次为:疗程太长、对治疗效果的感知、不方便继续获取药物、经济原因.结论 AR患者SLIT脱落率较高,年龄、性别因素对脱落率的影响无明显差异;脱落最多的月份位于用药的第3、4月份.加强患者教育、加强随访、延长首次处方时长有助于减少脱落.
在新型冠状病毒肺炎疫情下,耳鼻咽喉-头颈外科(ORL-HNS)在门诊和急诊患者的诊治,实施ORL-HNS手术,以及术后管理和随访等环节面临新的挑战.文章结合最新的文献报道,针对以上问题深入思考,探讨并总结一部分临床应用经验,为ORL-HNS同道提供一些参考,以达到保护医护人员安全和保障患者健康的目的.
该文研究水溶性富勒烯C60在体外对肝细胞脂肪变性的改善效果.首先利用游离脂肪酸诱导Huh6和WRL68细胞,建立肝细胞脂肪变的体外模型,再用水溶性富勒烯C60干预脂肪变细胞,利用尼罗红染色法检测胞内的脂质蓄积程度,通过检测细胞内甘油三酯(TG)的含量、细胞活性氧(ROS)水平、超氧化物歧化酶(SOD)活力、还原性谷胱甘肽(GSH)和三磷酸腺苷(ATP)含量变化,比较C60的作用效果.结果 显示,游离脂肪酸诱导使得细胞蓄积脂滴明显增多,且TG和ROS水平显著升高,而C60处理使得细胞脂肪蓄积减少,TG和ROS水平均下降,尤其是对氧化应激反应较为敏感的Huh6细胞,C60的改善效果更佳.总之,C60能有效改善肝细胞脂肪变性的程度,并缓解氧化应激所造成的细胞损伤.
目的 总结无冠窦补片在Standford A型夹层根部成形手术中应用效果.方法 采用回顾性研究方法,选择2008年3-5 月86例Standford A型主动脉夹层患者(A组)和2018年6 月至2020年10 月66例Standford A型夹层患者(B组)在我院行"孙氏手术"手术,A组手术中在主动脉根部行主动脉壁与右心耳做内引流,B组手术中主动脉根部采用无冠窦补片,主动脉根部血管壁采用"三明治"缝合加固的方法,右无瓣膜交界行悬吊成形.分析两组间手术时间、术中出血量、体外循环时间、术中输注红细胞量、术后再次开胸手术止血例数、术后24 h总引流量、术后输红细胞量、术后发生肺部并发症例数、术后病死率.结果 B组患者在手术时间、体外循环时间、术中输注红细胞量、术后再次开胸手术止血例数、术后24 h总引流量、术后输红细胞量、术后发生肺部并发症例数、术后病死率等方面均明显低于A组.结论 Standford A型主动脉夹层手术中,主动脉根部采用无冠窦补片,主动脉根部血管壁采用"三明治"缝合加固的方法,可减少术后并发症,提高手术成功率.
经内镜逆行胰胆管造影(ERCP)已经成为治疗胆胰系统疾病的一线微创诊疗方法,它也是目前消化内镜技术中难度最大和风险最高的操作之一,相关并发症时有发生。十二指肠穿孔是ERCP最严重的并发症,术中穿孔发生率0.08%~0.6%,病死率8%~23%[1],需要迅速作出诊断和及时治疗,以改善患者预后。本文回顾分析西部战区总医院消化内科发生的ERCP相关十二指肠穿孔4例(均为StapferⅠ型),3例经内镜下治疗,1例行外科手术,根据临床资料结合文献总结合报告如下。
Background Critically ill coronavirus disease 2019 (COVID-19) patients may suffer persistent systemic inflammation and multiple organ failure, leading to a poor prognosis. Research question To examine the relevance of the novel inflammatory factor heparin-binding protein (HBP) in critically ill COVID-19 patients, and evaluate the correlation of the biomarker with disease progression. Study design and methods 18 critically ill COVID-19 patients who suffered from respiratory failure and sepsis, including 12 cases who experienced a rapidly deteriorating clinical condition and six cases without deterioration, were investigated. They were compared with 15 age- and sex- matched COVID-19-negative patients with respiratory failure. Clinical data were collected and HBP levels were investigated. Results HBP was significantly increased in critically ill COVID-19 patients following disease aggravation and tracked with disease progression. HBP elevation preceded the clinical manifestations for up to 5 days and was closely correlated with patients’ pulmonary ventilation and perfusion status. Interpretation HBP levels are associated with COVID-19 disease progression in critically ill patients. As a potential mediator of disease aggravation and multiple organ injuries that are triggered by continuing inflammation and oxygen deficits, HBP warrants further study as a disease biomarker and potential therapeutic target.
目的 分析鼻内镜手术治疗鼻乳头状瘤的方法及疗效.方法 回顾性分析2011年1月~2018年12月123例住院鼻内镜手术的鼻乳头状瘤临床资料.根据病变程度和范围,选择经典鼻内镜手术、鼻内镜中下鼻道联合开窗术、鼻内镜辅助下Caldwell-Luc手术、鼻内镜下泪前隐窝入路手术、Draf手术以及鼻内镜下辅助鼻侧切开术等术式.分析术后病理分型比例,病变累及部位、范围、术后复发率.结果 随访2~8年,中位随访时间29个月.病理分型比例为外翻性乳头状瘤32.5%(40例)、内翻性乳头状瘤61.8%(76例)、嗜酸性细胞乳头状瘤5.7%(7例).外翻性乳头状瘤未见复发病例,内翻性乳头状瘤复发率为13.2%(10例)、嗜酸性细胞乳头状瘤复发率为14.3%(1例).结论 针对鼻乳头状瘤的不同病理类型、病变范围、病变累及的部位,采用合适的鼻内镜下手术进路和方式,结合术后密切随访处理,能安全有效的切除病灶,降低复发率.
Objective:To establish the murine models of allergic airway inflammation, and to investigate the biological rhythm expression of substance P in it. Method:Eighty-four BALB/c mice were divided into 14 groups, which were airway inflammation groups(0: 00 group, 04: 00 group, 08: 00 group, 12: 00 group, 16: 00 group, 20: 00 group, 24: 00 group) and normal control groups(0: 00 group, 04: 00 group, 08: 00 group, 12: 00 group, 16: 00 group, 20: 00 group, 24: 00 group). The allergic airway inflammation models of mice were established by intraperitoneal injection of ovalbumin(OVA), nasal challenge and aerosol inhalation with OVA. The plasma substance P levels were measured by ELISA. The expression of substance P in nasal mucosa, left lung tissue and left bronchial tissue during different time periods was obversed with RT-PCR and immunohistochemical technique. Result:In allergic airway inflammation groups, the plasma substance P levels were higher than in normal control groups(P<0.05), and 0: 00 group(321.99±28.93) pg/mL, 04: 00 group(310.76±25.31) pg/mL and 24: 00 group(335.62±28.29) pg/mL were higher than other experimental groups(P<0.05). The expression of substance P mRNA in nasal mucosa, left lung tissue and left bronchial tissue was higher than control groups(P<0.01). By observing immunohistochemical sections, the expression of substance P in allergic airway inflammation groups was higer than control groups. Conclusion:The expression of substance P is high in allergic airway inflammation mice and the peaks are during 04: 00-08: 00 in the early morning, which may provide new basis for treating allergic airway inflammation.
目的 探讨额窦中隔气房(FSC)的影像学特征及内镜下临床特征.方法 收集2016年7—12月鼻内镜手术术前鼻窦三维CT检查发现额窦中隔气房患者23例,按照Wormald额窦手术分型,行内镜下额窦手术,术中开放FSC,明确额窦引流通道与FSC的位置关系及临床特征.结果 鼻窦CT影像学显示:FSC开口在额窦内6例,开口在额隐窝者17侧;FSC单个气房者16例,2个气房者7例;所有患者均行内镜下额窦手术,Wormald 3级手术17例,Wormald 5级手术3例(复发性鼻息肉病骨质硬化明显2例、复发性乳头状瘤1例),Wormald 6级手术1例;经额隐窝径路内镜下开放FSC 18例,经额窦底近中线开放FSC 5例.结论 术前鼻窦CT三维重建,明确FSC及其与额窦引流通道影像学特征;内镜下经额隐窝径路或额窦底中线径路开放FSC,是额窦手术的重要步骤.